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Infection with a Ratborne Hantavirus in US Residents Is Consistently 
Associated with Hypertensive Renal Disease 
Gregory E. Glass, Alan J. Watson, James W. LeDuc,* 
Gabor D. Kelen, Thomas C. Quinn, and James E. Childs* 
Department of Immunology and Infectious Diseases, Johns Hopkins 
University School of Hygiene and Public Health, and Department of 
Nephrology and Divisions of Emergency Medicine and of Infectious 
Diseases, Johns Hopkins School of Medicine, Baltimore; Disease 
Assessment Division, Department of Epidemiology, US Army Medical 
Research Institute of Infectious Diseases, Fort Detrick; Laboratory of 
Immunoregulation, National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, Bethesda, Maryland 
A survey of 8080 subjects was conducted in Baltimore, examining the association between 
infection with hantaviruses and renal disease. Two groups (N ^  6060) with no known risk factors 
were selected to establish a baseline antibody prevalence. Overall, antibody prevalence was 
0.250Zo. Seroprevalence increased with age, without sex- or race-related ifferences. Patients with 
proteinuria showed the same patterns of infection but were more commonly seropositive (1.460Zo) 
than the reference group (OR, 3.23; P < .05). Infection among dialysis patients with end-stage 
renal disease was 2.760Zo, significantly higher than in the reference group (OR, 5.03; P < .05). In 
the proteinuria nd the dialysis groups, hantavirus infection was consistently associated with a 
diagnosis of hypertensive renal disease. The association was unrelated to other chronic renal 
disease diagnoses. Overall, 6.507o f patients with end-stage renal disease due to hypertension 
were seropositive for a hantavirus. These data suggest that hantavirus infection is associated with 
hypertensive renal disease. 
Hantaviruses (family Bunyaviridae), the etiologic agents 
of hemorrhagic fever with renal syndrome (HFRS), are dis- 
tributed worldwide, primarily in rodent reservoirs [1]. HFRS 
varies in severity depending on the specific infecting hanta- 
virus but is typically defined by fever, transient renal dys- 
function, and, less commonly, hemorrhage. Although pri- 
marily recognized from Korea, China, Russia, and 
Scandinavia, HFRS now is being identified from many coun- 
tries in Europe and Asia not previously thought to be en- 
demic for these viruses [2, 3]. 
Studies in North America have led to the isolation of han- 
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taviruses from several species of rodents [4-8], and human 
serologic surveys have demonstrated antibodies in geographi- 
cally and occupationally diverse groups, ranging from fores- 
ters to shipyard workers [7, 9-12]. In the United States, stud- 
ies using plaque reduction neutralization (PRN) tests with a 
library of representative hantaviruses have clearly linked an- 
tibody in humans from Baltimore to domestically acquired 
infection with a strain of Seoul virus, a Norway rat (Rattus 
norvegicus)-2LSSocmizd hantavirus [10, 11]. 
Even though human infection with hantaviruses has been 
demonstrated in the United States, there have been no docu- 
mented cases of HFRS nor any descriptions of disease accom- 
panying seroconversion to a hantavirus. A single possible 
case of HFRS due to Leakey virus, a house mouse (Mus 
musculus)-associated hantavirus, has been reported but not 
confirmed [8]. The failure to recognize HFRS in the United 
States has led to the hypothesis that domestic strains of han- 
tavirus may produce asymptomatic infections or atypical dis- 
ease [13] or that human exposures to these viruses (or con- 
tacts with their rodent reservoirs) occur less often than in 
other countries. 
Despite the absence of acute disease, there is epidemio- 
logic evidence that infection with hantaviruses, even where 
endemic HFRS is not recognized, is associated with chronic 
renal disease. In Baltimore, infection with a ratborne hanta- 
virus, as evidenced by neutralizing antibody, was associated 
with hypertensive renal disease and hypertension among in- 
ner-city hospital patients with proteinuria [14]. Although re- 
covery from HFRS is usually believed to be complete, re- 
ports from locations endemic for the disease also indicate 
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that some percentage of patients do suffer long-term se- 
quelae [15-18]. 
This study was designed to investigate intensively the epi- 
demiology of locally acquired hantavirus infections in Balti- 
more and to examine the association of infection with 
chronic renal disease. We established baseline antibody prev- 
alence to the local Seoul virus strain, Baltimore rat virus, in a 
large sample of city residents. Then we prospectively moni- 
tored selected inpatients at a large inner-city hospital for anti- 
bodies to hantaviruses. Finally, we sampled renal dialysis 
patients from four hemodialysis units within the city and 
examined the association between hantavirus antibody and 
specific diagnoses of renal disease, with the a priori predic- 
tion that seropositivity would be positively associated with 
hypertensive renal disease [14]. 
Materials and Methods 
Serologic surveys. Four groups were selected for study; two 
had no known risk factors for exposure to hantaviruses except 
residing in a city that had infected rats [11, 19]. These two 
groups, described below, served as a reference sample to provide 
background antibody prevalence levels for Baltimore. 
The third group was drawn from patients at Johns Hopkins 
Hospital (JHH) who received quantitative urine total protein 
(UTP) tests. Proteinuria was used as an inclusion criterion, as it 
is a consistent laboratory finding in cases of HFRS regardless of 
the causative hantavirus [20-22]. As proteinuria also serves as a 
general marker of renal dysfunction, this group was used to eval- 
uate the association between hantavirus infection and underly- 
ing diagnoses of renal disease. 
The fourth group consisted of patients from inner-city Balti- 
more with end-stage renal disease on maintenance hemodialy- 
sis. This group was selected to examine the hypothesis that han- 
tavirus infection is associated with specific chronic renal 
sequelae, especially hypertensive renal disease [14]. 
Sexually transmitted disease (STD) group. Sera were gath- 
ered from 2660 patients visiting a Baltimore STD clinic from 
March 1985 through March 1988. Interviews were conducted 
twice weekly from consecutive willing individuals. Information 
on age, sex, race, and residence were obtained from a short ques- 
tionnaire given orally. Details of data collection procedures and 
serologic results from a specific subsample (N = 1180) of the 
STD group were reported previously [11]. Data from the entire 
STD group, including the previously reported subsample, are 
included here as part of the larger reference sample. 
JHH Emergency Department group. Sera were obtained 
from 3400 patients as part of an AIDS study conducted by the 
JHH Department of Emergency Medicine (ER). Individuals 
were enrolled from June to August 1988. Information was gath- 
ered on age, sex, race, and zip code of residence. Some sampling 
weight was given to the younger age groups. Details of the proce- 
dures are described elsewhere [23]. 
JHH proteinuria group. Sera were obtained from 1766 pa- 
tients whose physicians requested 24-h UTP tests and blood 
chemistry panels from the Blood Chemistry Department at 
JHH. Samples were gathered from January 1986 to May 1990 
from all patients with proteinuria ^50 mg/24 h for whom 
serum samples were available. Also, the first 2 subjects with 
proteinuria < 150 mg/24 h from a randomly selected day in each 
week were chosen to form an internal, second reference group to 
assess the association between hantavirus infection and protein- 
uria. 
Information was obtained on age and sex for all patients. How- 
ever, racial status was not generally available and could be ob- 
tained only by reviewing patients' charts. Medical histories were 
obtained from all seropositive and a subsample of age- and sex- 
matched seronegative patients (see below) by researchers 
blinded for serologic status. Details of the procedures and prelim- 
inary findings on the association between hantavirus antibody 
and hypertensive renal disease are described elsewhere [14]. 
Dialysis group. Sera were obtained from 1988 to 1991 from 
254 patients with end-stage renal disease. All patients (N = 328) 
in four hemodialysis units serving the inner-city area of Balti- 
more were eligible for the study. Participants provided a blood 
sample and information on age, sex, race, and residence by zip 
code. 
The International Classification of Diseases (ICD) code for 
the diagnosis of underlying renal disease was obtained from pa- 
tient records, before serologic testing, and cross-checked with 
the patient's primary health care provider. ICD codes were ag- 
gregated into diagnostic groups for underlying renal disease 
[24]. These groups included hypertensive renal disease (ICD 
codes 401. and 403.), diabetic renal disease (codes 250., 583.71, 
and 583.81 if diabetes was specified as the underlying cause of 
disease), drug nephrotoxicity (code 584.5), glomerulosclerosis 
(code 581.), glomerulonephritis (code 582.), nephrolithiasis 
(code 592.), polycystic kidney disease (code 753.), and other. 
Information on dialysis patients who did not participate in 
this study was provided in aggregate without identifiers. These 
data were used to check for participation bias on the basis of 
demographic and diagnostic variables. 
Serologic assays. Hantavirus infection was determined sero- 
logically. Initially, all sera were screened at 1:100 dilutions for 
IgG to prototype Hantaan virus (strain 76-118) by ELISA [25]. 
Antigen was derived from Vero-E6-infected cell lysates as de- 
scribed previously [26]. Uninfected Vero-E6 cell lysates were 
included in duplicate wells as controls. Samples with optical 
densities ^ SD above the mean of 3 negative control sera in- 
cluded on each plate were tested further. 
Specific antibody in each positive screen was confirmed by 
PRN assays using Baltimore rat virus, Hantaan virus, and Pros- 
pect Hill virus, a vole-associated hantavirus isolated from Micro- 
tus pennsylvanicus captured in Frederick, Maryland [6]. Differ- 
ential neutralization titers, which vary by 4- to 32-fold among 
homologous and heterologous viruses [10, 25], were used to 
identify the particular infecting hantavirus. A neutralization 
titer of ^1:10 for sera that reduced plaque formation by ^80*20 
was considered positive. 
Data analysis. Analyses were done with either SAS [27] or 
BMDP [28] statistical software systems. Descriptive analyses 
were done for all variables, and initial comparisons were made 
by contingency table, with calculations of odds ratios (OR) and 
95*^ confidence intervals (CI) as appropriate. Mantel-Haenszel 
weighted ORs were used to compare age-stratified prevalence 
data between various groups. 
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For analyses exploring the association of hantavirus antibody 
and chronic disease in the dialysis group, all frequency variables 
were tested with Fisher's exact test or as ORs with CI. Two- 
tailed tests were used in all comparisons. 
Conditional logistic regression analysis was done on the JHH 
proteinuria group with matched seropositive (cases) and seroneg- 
ative patients (controls). Patients were matched for age (within 3 
years) and sex, with 5 randomly selected controls per case. This 
analysis included 15 cases that were previously described and 
analyzed by univariate methods [14]. Information was obtained 
on race, residence (subsequently coded as city resident or not), 
current and previous occupation, hospital unit, reason for ad- 
mission, and the occurrence of any chronic diseases. 
Preliminary study [ 14] had shown that the only variables that 
differed between infected and uninfected individuals were the 
presence of hypertensive renal disease, hypertension, and 
stroke. Therefore, the initial regression model included these 
variables as well as race. Other clinical and demographic vari- 
ables were subsequently added and were kept in the model only 
if they significantly improved the fit of the model to the outcome 
of serologic status. 
All demographic and clinical data from the JHH proteinuria 
patients were obtained by two reviewers independently screen- 
ing medical charts without prior knowledge of the serologic sta- 
tus of the patients. All demographic and diagnostic data were 
obtained from the dialysis group before serologic testing. Statis- 
tical examination of primary diagnoses underlying chronic renal 
disease for both the JHH proteinuria and dialysis groups was 
done after grouping ICD codes into four categories: no chronic 
renal disease, diabetes mellitus, hypertension, and other. 
Results 
Seroepidemiology 
Reference population. Among the two groups selected to 
establish background antibody prevalence in Baltimore, 11 
patients (0.32^) from the JHH ER and 4 patients (0.157c) 
from the STD clinic were seropositive to a hantavirus, as 
confirmed by PRN tests. All had highest neutralizing titers to 
Baltimore rat virus, suggesting exposure to the local rat-asso- 
ciated hantavirus. There were no statistically significant dif- 
ferences in prevalence between the ER and STD groups by 
race, sex, or age, stratified by 20-year age groups (table 1). 
On the basis of similarities of low antibody prevalence 
across all demographic classifications, the two groups were 
combined into a single reference group for further analyses. 
Infection patterns in the remaining groups were compared to 
those of the reference group. However, as a more conserva- 
tive test, comparisons also were done using only the ER 
group as a standard. There were no differences in the results 
using the entire reference group or only the ER group, so 
results of the reference group comparisons are shown. 
In the reference group, seroprevalence increased from 
0.1 \7c in persons ^ 1 years old (^ ^ 1839) to 0.70^ in those 
^0 (n = 284; table 2). There were no differences in sero- 
Table 1. Prevalence of neutralizing antibody to Baltimore rat 
virus, a strain of Seoul virus, in patients visiting Johns Hopkins 
Emergency Medicine Department (ER) and a sexually transmitted 
disease clinic (STD) in Baltimore, 1985-1989. 
ER STD 
No. % No. % 
Variable positive/total positive positive/total positive 
Race 
African-American 9/2474 0.36 4/2563 0.16 
Caucasian 2/897 0.22 0/83 0 
Other 0/29 0 0/14 0 
Sex* 
Male 7/1820 0.38 4/1878 0.21 
Female 4/1578 0.25 0/782 0 
Age, years 
<21 2/1067 0.19 0/772 0 
21-40 4/1663 0.24 4/1775 0.23 
41-60 3/399 0.75 0/100 0 
>60 2/271 0.74 0/13 0 
c Data missing for 2 subjects. 
prevalence associated with race (0.26^ African-Americans 
vs. 0.207c all others; OR, 1.32; CI, 0.28-8.48) or sex (0.307c 
male subjects vs. 0.17^ female subjects; OR, 1.76; CI, 
0.52-6.54). 
JHH proteinuria group. Antibody prevalence was \.467c 
among patients in the JHH proteinuria population whose 
proteinuria ^50 mg/24 h (n = 1507); 22 of these patients 
were seropositive to a hantavirus, and all had highest neutral- 
izing titers to Baltimore rat virus. Seroprevalence also in- 
creased with age in this group from zero in those ^ 1 years 
old to 2.217c in those ^0 (table 2). ORs of seroprevalence 
based on age-stratified comparisons between the JHH pro- 
teinuria population and the reference group ranged from 
2.69 to 3.68 and were consistently elevated over all strata. 
Although statistical significance in each age stratum was pre- 
cluded by small numbers of seropositive subjects, there was a 
significant overall increase in antibody prevalence in the 
JHH proteinuria group when adjusted for age (Mantel- 
Haenszel weighted OR, 3.23; CI, 1.35-7.44). 
As with the reference group, there was no association be- 
tween hantavirus infection and sex (1.27% male subjects vs. 
1.597c female subjects; OR, 0.80; CI, 0.30-2.04). There was 
a higher proportion of seropositive subjects among African- 
Americans than among other races when seropositive sub- 
jects were compared with matched controls (see below); how- 
ever, the difference was not statistically significant (OR, 
3.56; CI, 0.92-16.06). 
In total, 259 JHH inpatients were sampled who had UTP 
tests but showed proteinuria ^50 mg/24 h. In this second, 
internal reference group, only 1 patient was seropositive for 
hantavirus. Infection was with BRV. The level of association 
between hantavirus antibody and the occurrence of protein- 
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Table 2. Race, sex, and age-associated seroprevalence to Baltimore rat virus based on neutraliza- 
tion antibody tests in reference, proteinuria, and dialysis groups. 
Reference Proteinuria Dialysis 
group, 
% positive % positive % positive 
Variable (nf (n) OR (n) OR 
Race 
African-American 0.26(5037) ? ? 3.37(208) 13.46 
Other 0.20(1023) ? ? 0.00(46) ? 
Sex 
Male 0.30(3698) 1.27(628) 4.32 2.72(110) 9.40 
Female 0.17(2360) 1.59(879) 9.53 2.78(144) 16.83 
Age, years 
<21 0.11(1839) 0.0(161) ? ? ? 
21-40 0.23(3438) 0.62(481) 2.69 1.92(52) 8.41 
41-60 0.60(499) 2.18(367) 3.68 0.94(106) 1.56 
>60 0.70(284) 2.21(498) 3.18 5.43(92) 8.10 
Overall 0.25(6060) 1.46(1507) 3.23 2.80(250) 5.03 
NOTE. Proteinuria group includes only patients with urine total protein ^ 50 mg/24 h. Odds ratios (ORs) 
use appropriate age class from reference group for comparison. Overall ORs are weighted Mantel-Haenszel ORs. ? , not calculated due to lack of data. 
* Includes total figures from sexually transmitted disease and Johns Hopkins Emergency Medicine Department 
groups from table 1. 
uria within the hospital population (OR, 3.82; CI, 0.55- 
7.65) was similar to that between the JHH proteinuria group 
and the external reference group. 
Hemodialysis group. Among patients using hemodialysis 
because of end-stage renal disease, hantavirus antibody prev- 
alence was 2.76^ (7/254). All patients had highest neutraliz- 
ing antibody titers to Baltimore rat virus. Seroprevalence 
tended to increase by age stratum, ranging from 1.92^ in 
those 21-40 years old (there were no patients sampled in the 
^1 years group) to 5.43^ in those ^0 (table 2). 
Overall, the dialysis population had a significantly higher 
prevalence of infection when stratified by 20-year age catego- 
ries than the reference group (Mantel-Haenszel weighted 
OR, 5.03; CI, 1.50-17.68). There were no significant differ- 
ences in infection associated with sex (2.127c male subjects 
vs. 2.187c female subjects; OR, 0.98; CI, 0.17-5.32) or race 
(3.37^ African-American vs. 0.00^ other; P = .36, Fisher's 
exact test). 
Association with Chronic Disease 
JHH proteinuria group. Crude analyses between demo- 
graphic and clinical features and hantavirus infection indi- 
cated that hypertension, stroke, and hypertensive renal dis- 
ease were associated with the presence of hantavirus 
antibodies (table 3). Conditional logistic regression analysis 
demonstrated significant correlations among these three vari- 
ables, and hypertension and stroke did not meet the criterion 
for inclusion in the final model. 
Race was included in the final model a priori as a factor 
known to be confounded with hypertensive disease. By using 
conditional logistic regression and controlling for race (table 
3), hantavirus-seropositive individuals had a significantly 
higher frequency of hypertensive renal disease (OR, 16.19; 
CI, 3.05-86.00) than did seronegative hospital patients with 
proteinuria (table 3). There was no overall difference in the 
frequency of occurrence of the two major chronic diseases 
Table 3. Crude and adjusted odds ratios (ORs) and 95*30 confi- 
dence intervals (CIs) for variable obtained from Johns Hopkins 
Hospital proteinuria group analyzed for their associations with han- 
tavirus antibody. 
Variable Crude OR CI 
Residence (city vs. other) 1.24 0.43-3.60 
Sex (male vs. female) 0.81 0.21-3.16 
Hypertension (present vs. absent) 5.20 1.11-24.41 
Renal disease (none vs. any 
etiology) 1.27 0.92-1.76 
Stroke (present vs. absent) 3.63 1.34-9.86 
Diabetes mellitus (present vs. 
absent) 0.42 0.14-1.28 
Hypertensive renal disease 
(present vs. absent) 20.50 6.03-69.70 
Race (African-American vs. 
other) 3.33 0.94-11.82 
Adjusted OR CI 
Hypertensive renal disease 
(present vs. absent)* 16.19 3.05-86.00 
Race (African-American vs. 
other)* 1.26 0.28-5.79 
* Included in conditional logistic regression model. 
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reported for this group, diabetes mellitus (OR, 0.42; CI, 
0.14-1.28) and renal disease (OR, 1.27; CI, 0.92-1.76), in- 
dicating the specificity of the association. No other clinical or 
demographic variable, including residence, was associated 
with hantavirus infection (table 3). 
Dialysis group. Primary diagnoses for the cause of end- 
stage renal disease were available for all 328 patients who 
were using the four hemodialysis units. In this population, 
the leading causes of end-stage renal disease were hyperten- 
sion (40.7^) and diabetes mellitus (29.0^). Other significant 
causes of renal disease were glomerulonephritis due to 
various causes (1.67c), obstructive uropathies (3.2^), poly- 
cystic disease (2.6^), and intravenous drug use (2.27c). There 
were no statistical differences by race, sex, or primary disease 
diagnosis (based on hypertension, diabetes mellitus, or 
other) between those who participated in the study and those 
who did not (P > .50 in all tests). 
All 7 seropositive patients had hypertensive renal disease 
as the primary diagnosis underlying their end-stage renal dis- 
ease (P = .0018, Fisher's exact test). Overall, among the 
hypertensive population with end-stage renal disease, 6.5^ 
(7/109) were seropositive for a ratborne hantavirus. There 
was no significant difference (t = 1.84; P> .05) in the ages of 
patients with hypertensive renal disease (mean ? SD, 57.1 ? 
15.4 years) and patients with renal disease due to other 
causes (54.1 ? 14.4 years). 
Discussion 
The data presented here complement our previous report 
on the association between hantavirus infection and a spe- 
cific chronic renal disease [ 14]. Although the data are associa- 
tional and cannot address relevant factors, such as the tem- 
poral relationship between infection and the development of 
renal disease, they do support the hypothesis of a causal rela- 
tionship between infection with a ratborne hantavirus and 
the development of hypertensive renal disease. First, the 
strength of association between hantavirus antibody and hy- 
pertensive renal disease is high, resulting in an OR of 16.19 
in the proteinuric patient group and a significant association 
(P = .0018) in the dialysis group. Second, the association 
with hypertensive renal disease is consistent across both pa- 
tient groups. Finally, the association between hantavirus an- 
tibody and hypertensive renal disease was specific to this 
diagnosis and unrelated to other chronic renal disease. 
Hantavirus infection in rodents in the United States was 
demonstrated shortly after the isolation of prototype Han- 
taan virus nearly a decade ago [29, 30]. Several hantaviruses 
have been isolated from different rodent species and from 
varied geographic sites in the continental United States [4- 
8]. Subsequent serologic surveys documented human infec- 
tion by hantaviruses in US residents [7, 9-12]. However, no 
definite acute cases of HFRS have been reported, although 
disease consistent with HFRS has been noted in 3 serocon- 
verting patients among the JHH proteinuria group [31]. 
In the absence of well-defined domestic cases of HFRS, 
various hypotheses have been proposed to explain the rea- 
sons for global variation in disease patterns. These potential 
explanations include that infection by domestic strains of 
hantaviruses may be less virulent and produce subclinical or 
atypical disease and that the frequency of infection may be so 
low that the few cases of disease go unrecognized. Although 
there are increasing data from restriction pattern analyses 
and sequence comparisons demonstrating strain variation 
among hantaviruses, little information is available to link 
these patterns to HFRS cases of differing severity [32, 33]. 
However, serologic surveys do provide insights on the 
level of hantavirus infection in various geographic locations. 
Our current and previous studies demonstrate that overall 
hantavirus infection rates are lower in Baltimore than in 
areas endemic for HFRS. Antibody prevalence in the refer- 
ence group (0.25^) is an order of magnitude lower than has 
been reported from cross-sectional surveys from either Euro- 
pean (1.97c in Sweden [34]) or Asian (3.8^o in Korea [35]) 
HFRS-endemic locations. These comparisons suggest that 
lower domestic exposure may contribute to the difficulties in 
recognizing acute disease if it occurs. However, the data from 
Baltimore are conservative estimates of infection, as they are 
based on results confirmed by PRN tests, while results from 
other locations are based solely on indirect fluorescent anti- 
body tests or ELISA. 
The pattern of infection in Baltimore also differs some- 
what from surveys of HFRS cases from regions endemic for 
the disease, indicating that the epidemiology of transmission 
also may vary. In Baltimore, there was no difference in anti- 
body prevalence between male and female subjects in any of 
the groups surveyed. Cases of HFRS typically show a male 
bias of 5-6:1 in HFRS-endemic locations, presumably re- 
flecting occupational exposures [34-36], although the distri- 
bution of hantavirus antibody may be less disparate [35]. 
This difference suggests that exposure in inner-city popula- 
tions to ratborne hantaviruses may occur in or near resi- 
dences, rather than at the workplace [37]. As such, the pri- 
mary at-risk group in the United States may be urban 
residents rather than rural populations, as is the pattern in 
HFRS-endemic locations [37]. 
Although background antibody prevalence was low, the 
JHH proteinuria group had a roughly threefold increase in 
infection rate compared with that of the age-stratified refer- 
ence group. As proteinuria is a consistent clinical feature of 
HFRS, such a finding suggested an association between in- 
fection with a hantavirus and some acute renal dysfunction. 
However, r^157c of the seropositive patients in the protein- 
uria group had serologic tests on paired sera collected over 
periods of weeks that revealed unchanging titers (unpub- 
lished data). This indicated their antibody was presumably 
the result of infection in the past, and their current protein- 
uria, if related to hantavirus infection, was a manifestation of 
long-term or chronic disease. 
The observation that hantavirus infection was also three- 
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fold higher among the patients with proteinuria than in the 
internal reference group tested for UTP but without protein- 
uria is consistent with the association of hantavirus infection 
and renal dysfunction. It appears unlikely that the associa- 
tion is an artifact of the selection process, as seropositive 
subjects did not differ from seronegative subjects in any dem- 
ographic characteristic, and the overall prevalence of chronic 
renal disease due to any factor did not differ between the two 
groups (table 3). The absence of any indicative demographic 
factor, including area of residence and occupation, suggests 
that socioeconomic factors did not differ between the groups. 
However, it is likely that exposure to rats per se is linked to 
economic conditions [37]. 
The statistical association of hantavirus infection with 
chronic renal disease also is consistent with our long-term 
observations of the 3 patients from the proteinuria popula- 
tion who showed changing antibody titers, indicating sero- 
conversion following acute hantavirus infection (unpub- 
lished data). Two of the 3 patients were subsequently noted 
to have evidence of chronic renal dysfunction (serum urea 
nitrogen ^ 2 mg/dL; serum creatinine > 1.2 mg/dL) for > 1 
year, and 1 of these patients developed end-stage renal dis- 
ease requiring maintenance hemodialysis. The patient had a 
diagnosis of hypertensive renal disease determined indepen- 
dently of serologic status. 
The consistent finding that distinguishes between the han- 
tavirus antibody-positive patients and the uninfected pa- 
tients is the association with hypertensive renal disease. 
Nearly 75^ of the infected JHH proteinuria group and all of 
the seropositive dialysis population had this diagnosis as the 
underlying cause of their renal disease. Hantaviruses are 
known to preferentially infect vascular endothelial cells [38] 
and possibly renal tubular epithelium [39]. Acute vascular 
endothelial damage is recognized as the major cause of pa- 
thology in HFRS [40]. Damage to these target cells could 
produce the basic lesions resulting in the observed renal dys- 
function in acute cases. Our data support a hypothesis that 
these lesions result in permanent vascular or tubular damage 
that contributes to the later development of hypertensive 
renal disease. 
Previously, most studies have reported complete although 
protracted recovery from HFRS. Exceptions are the reports 
in the Russian literature indicating 9^ of 85 patients devel- 
oped "elevated arterial pressure" 1-10 years after acute 
HFRS [17], and a study by Rubini et al. [15]. They noted 
that 2-5 years after apparent recovery from HFRS, 7 of 13 
patients had acquired hyposthenuria, and 2 of 13 had devel- 
oped hypertensive vascular disease. In addition, they re- 
ported 1 case of chronic glomerulonephritis and 2 cases of 
pyelonephritis among 31 cases after presumptive recovery. 
Most recently, Kleinknecht and Rollin [41] have observed 
the development of hypertension in 2 patients after HFRS. 
Other authors have not highlighted findings suggestive of 
chronic renal sequelae following acute HFRS [42, 43]. Only 
Lahdevirta's study [42] provides sufficient detail to reexam- 
ine this issue. His data (table 21 in [42]) show that ~70^ of 
his patients in follow-up from HFRS were hypertensive (dia- 
stolic ^9 mm Hg), and 20*20 of the patients had diastolic 
blood pressures of ^95 mm Hg. Nearly 30^ had decreased 
renal function. More recent prospective studies of smaller 
numbers of patients from areas endemic for HFRS also show 
that 10^-^ of patients subsequently develop persistent 
renal dysfunction and essential hypertension [44]. An in- 
creased prevalence of hantavirus antibody in patient popula- 
tions with renal disease also has been reported from coun- 
tries where HFRS is rare or unreported, such as Ireland [45]. 
As these studies involve different hantaviruses (Hantaan, 
Seoul, and Puumala), the occurrence of chronic renal disease 
in a proportion of individuals appears to be a common char- 
acteristic of hantavirus infection, whether or not acute dis- 
ease is apparent. 
If these results are confirmed, they would suggest that 
some fraction of the substantial number of cases of hyperten- 
sive renal disease and resulting hypertension in the United 
States may be of infectious origin. Domestic exposure to rat- 
borne hantaviruses would presumably be greatest in the in- 
ner cities of the United States [37]. However, the problem 
could be global, given the worldwide distribution of Seoul 
virus and Rattus species [46]. Future research efforts should 
focus on confirming this observed association in other popu- 
lations and on prospective follow-up in HFRS-endemic loca- 
tions of large numbers of confirmed HFRS patients over pe- 
riods sufficient for establishing a diagnosis of chronic renal 
disease. 
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